The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Modafinil (NDC 70771-1052). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
NDC 70771-1051-3
Modafinil Tablets USP, 100 mg
30 Tablets
Rx only
Modafinil Tablets Usp, 100mg And 200mg (B5ea9560 7195 403b 85bd Dd17d4467383 02)
NDC 70771-1052-3
Modafinil Tablets USP, 200 mg
30 Tablets
Rx only
Modafinil Tablets Usp, 100mg And 200mg (B5ea9560 7195 403b 85bd Dd17d4467383 03)
* Please review the disclaimer below.
